Cargando…

Subtype-Independent ANP32E Reduction During Breast Cancer Progression in Accordance with Chromatin Relaxation

BACKGROUND: Chromatin state provides a clear decipherable blueprint for maintenance of transcriptional patterns, exemplifying a mitotically stable form of cellular programming in dividing cells. In this regard, genomic studies of chromatin states within cancerous tissues have the potential to uncove...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruff, Garrett L., Murphy, Kristin E., Smith, Zachary R., Vertino, Paula M., Murphy, Patrick J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684129/
https://www.ncbi.nlm.nih.gov/pubmed/34922480
http://dx.doi.org/10.1186/s12885-021-09077-9
_version_ 1784617554343362560
author Ruff, Garrett L.
Murphy, Kristin E.
Smith, Zachary R.
Vertino, Paula M.
Murphy, Patrick J.
author_facet Ruff, Garrett L.
Murphy, Kristin E.
Smith, Zachary R.
Vertino, Paula M.
Murphy, Patrick J.
author_sort Ruff, Garrett L.
collection PubMed
description BACKGROUND: Chromatin state provides a clear decipherable blueprint for maintenance of transcriptional patterns, exemplifying a mitotically stable form of cellular programming in dividing cells. In this regard, genomic studies of chromatin states within cancerous tissues have the potential to uncover novel aspects of tumor biology and unique mechanisms associated with disease phenotypes and outcomes. The degree to which chromatin state differences occur in accordance with breast cancer features has not been established. METHODS: We applied a series of unsupervised computational methods to identify chromatin and molecular differences associated with discrete physiologies across human breast cancer tumors. RESULTS: Chromatin patterns alone are capable of stratifying tumors in association with cancer subtype and disease progression. Major differences occur at DNA motifs for the transcription factor FOXA1, in hormone receptor-positive tumors, and motifs for SOX9 in Basal-like tumors. We find that one potential driver of this effect, the histone chaperone ANP32E, is inversely correlated with tumor progression and relaxation of chromatin at FOXA1 binding sites. Tumors with high levels of ANP32E exhibit an immune response and proliferative gene expression signature, whereas tumors with low ANP32E levels appear programmed for differentiation. CONCLUSIONS: Our results indicate that ANP32E may function through chromatin state regulation to control breast cancer differentiation and tumor plasticity. This study sets a precedent for future computational studies of chromatin changes in carcinogenesis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-09077-9.
format Online
Article
Text
id pubmed-8684129
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86841292021-12-20 Subtype-Independent ANP32E Reduction During Breast Cancer Progression in Accordance with Chromatin Relaxation Ruff, Garrett L. Murphy, Kristin E. Smith, Zachary R. Vertino, Paula M. Murphy, Patrick J. BMC Cancer Research Article BACKGROUND: Chromatin state provides a clear decipherable blueprint for maintenance of transcriptional patterns, exemplifying a mitotically stable form of cellular programming in dividing cells. In this regard, genomic studies of chromatin states within cancerous tissues have the potential to uncover novel aspects of tumor biology and unique mechanisms associated with disease phenotypes and outcomes. The degree to which chromatin state differences occur in accordance with breast cancer features has not been established. METHODS: We applied a series of unsupervised computational methods to identify chromatin and molecular differences associated with discrete physiologies across human breast cancer tumors. RESULTS: Chromatin patterns alone are capable of stratifying tumors in association with cancer subtype and disease progression. Major differences occur at DNA motifs for the transcription factor FOXA1, in hormone receptor-positive tumors, and motifs for SOX9 in Basal-like tumors. We find that one potential driver of this effect, the histone chaperone ANP32E, is inversely correlated with tumor progression and relaxation of chromatin at FOXA1 binding sites. Tumors with high levels of ANP32E exhibit an immune response and proliferative gene expression signature, whereas tumors with low ANP32E levels appear programmed for differentiation. CONCLUSIONS: Our results indicate that ANP32E may function through chromatin state regulation to control breast cancer differentiation and tumor plasticity. This study sets a precedent for future computational studies of chromatin changes in carcinogenesis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-09077-9. BioMed Central 2021-12-18 /pmc/articles/PMC8684129/ /pubmed/34922480 http://dx.doi.org/10.1186/s12885-021-09077-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Ruff, Garrett L.
Murphy, Kristin E.
Smith, Zachary R.
Vertino, Paula M.
Murphy, Patrick J.
Subtype-Independent ANP32E Reduction During Breast Cancer Progression in Accordance with Chromatin Relaxation
title Subtype-Independent ANP32E Reduction During Breast Cancer Progression in Accordance with Chromatin Relaxation
title_full Subtype-Independent ANP32E Reduction During Breast Cancer Progression in Accordance with Chromatin Relaxation
title_fullStr Subtype-Independent ANP32E Reduction During Breast Cancer Progression in Accordance with Chromatin Relaxation
title_full_unstemmed Subtype-Independent ANP32E Reduction During Breast Cancer Progression in Accordance with Chromatin Relaxation
title_short Subtype-Independent ANP32E Reduction During Breast Cancer Progression in Accordance with Chromatin Relaxation
title_sort subtype-independent anp32e reduction during breast cancer progression in accordance with chromatin relaxation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684129/
https://www.ncbi.nlm.nih.gov/pubmed/34922480
http://dx.doi.org/10.1186/s12885-021-09077-9
work_keys_str_mv AT ruffgarrettl subtypeindependentanp32ereductionduringbreastcancerprogressioninaccordancewithchromatinrelaxation
AT murphykristine subtypeindependentanp32ereductionduringbreastcancerprogressioninaccordancewithchromatinrelaxation
AT smithzacharyr subtypeindependentanp32ereductionduringbreastcancerprogressioninaccordancewithchromatinrelaxation
AT vertinopaulam subtypeindependentanp32ereductionduringbreastcancerprogressioninaccordancewithchromatinrelaxation
AT murphypatrickj subtypeindependentanp32ereductionduringbreastcancerprogressioninaccordancewithchromatinrelaxation